The Clinical Genetics of Hemophilia B (Factor IX Deficiency)
Connie H Miller1,2 1Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA; 2Synergy America, Inc., Duluth, GA, USACorrespondence: Connie H MillerDivision of Blood Disorders, National Center on Birth...
Guardado en:
Autor principal: | Miller CH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b68979fcea141e8b9e75cbc34b2202b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device
por: Cristina Olgasi, et al.
Publicado: (2021) -
The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
por: Haowei (Linda) Sun, et al.
Publicado: (2021) -
Genetic and Bioinformatic Strategies to Improve Diagnosis in Three Inherited Bleeding Disorders in Bogotá, Colombia
por: Juliana Lago, et al.
Publicado: (2021) -
Deficiency of ASGR1 in pigs recapitulates reduced risk factor for cardiovascular disease in humans.
por: Baocai Xie, et al.
Publicado: (2021) -
Deficiency of ASGR1 in pigs recapitulates reduced risk factor for cardiovascular disease in humans
por: Baocai Xie, et al.
Publicado: (2021)